Sands Capital Ventures, LLC 10x Genomics, Inc. Transaction History
Sands Capital Ventures, LLC
- $235 Million
- Q1 2025
A detailed history of Sands Capital Ventures, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Sands Capital Ventures, LLC holds 481,770 shares of TXG stock, worth $5.81 Million. This represents 1.79% of its overall portfolio holdings.
Number of Shares
481,770
Previous 481,770
-0.0%
Holding current value
$5.81 Million
Previous $6.92 Million
39.22%
% of portfolio
1.79%
Previous 2.62%
Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
305Shares Held
109MCall Options Held
228KPut Options Held
157K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.8MShares$155 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$134 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL7.1MShares$85.7 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$77.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.38MShares$64.9 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.15B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...